1
|
Cushing's syndrome.
|
Lancet
|
2006
|
5.19
|
2
|
Evaluation and management of adult hypoglycemic disorders: an Endocrine Society Clinical Practice Guideline.
|
J Clin Endocrinol Metab
|
2008
|
4.68
|
3
|
The tissue distribution of the mRNA of ghrelin and subtypes of its receptor, GHS-R, in humans.
|
J Clin Endocrinol Metab
|
2002
|
3.43
|
4
|
Pheochromocytoma: recommendations for clinical practice from the First International Symposium. October 2005.
|
Nat Clin Pract Endocrinol Metab
|
2007
|
3.25
|
5
|
AIP mutation in pituitary adenomas in the 18th century and today.
|
N Engl J Med
|
2011
|
3.14
|
6
|
The diagnosis and medical management of advanced neuroendocrine tumors.
|
Endocr Rev
|
2004
|
2.88
|
7
|
The ectopic adrenocorticotropin syndrome: clinical features, diagnosis, management, and long-term follow-up.
|
J Clin Endocrinol Metab
|
2005
|
2.80
|
8
|
The diagnosis and management of malignant phaeochromocytoma and paraganglioma.
|
Endocr Relat Cancer
|
2007
|
2.10
|
9
|
Ghrelin--a hormone with multiple functions.
|
Front Neuroendocrinol
|
2004
|
1.88
|
10
|
Cannabinoids and ghrelin have both central and peripheral metabolic and cardiac effects via AMP-activated protein kinase.
|
J Biol Chem
|
2005
|
1.83
|
11
|
Clinical review: Diagnosis and management of pituitary carcinomas.
|
J Clin Endocrinol Metab
|
2005
|
1.79
|
12
|
123I-metaiodobenzylguanidine (MIBG) scintigraphy for the detection of adrenal and extra-adrenal phaeochromocytomas: CT and MRI correlation.
|
Clin Endocrinol (Oxf)
|
2008
|
1.78
|
13
|
Etomidate in the management of hypercortisolaemia in Cushing's syndrome: a review.
|
Eur J Endocrinol
|
2012
|
1.73
|
14
|
The value of the low-dose dexamethasone suppression test in the differential diagnosis of hyperandrogenism in women.
|
J Clin Endocrinol Metab
|
2003
|
1.61
|
15
|
Discriminatory value of the low-dose dexamethasone suppression test in establishing the diagnosis and differential diagnosis of Cushing's syndrome.
|
J Clin Endocrinol Metab
|
2003
|
1.60
|
16
|
Unmasking of central hypothyroidism following growth hormone replacement in adult hypopituitary patients.
|
Clin Endocrinol (Oxf)
|
2007
|
1.50
|
17
|
90Y-edotreotide for metastatic carcinoid refractory to octreotide.
|
J Clin Oncol
|
2010
|
1.49
|
18
|
The orexigenic effect of ghrelin is mediated through central activation of the endogenous cannabinoid system.
|
PLoS One
|
2008
|
1.49
|
19
|
Clinical and endocrine responses to pituitary radiotherapy in pediatric Cushing's disease: an effective second-line treatment.
|
J Clin Endocrinol Metab
|
2003
|
1.47
|
20
|
The role of the aryl hydrocarbon receptor-interacting protein gene in familial and sporadic pituitary adenomas.
|
J Clin Endocrinol Metab
|
2008
|
1.42
|
21
|
Current treatment protocols can offer a normal or near-normal quality of life in the majority of patients with non-functioning pituitary adenomas.
|
Clin Endocrinol (Oxf)
|
2013
|
1.39
|
22
|
Clinical manifestations of familial paraganglioma and phaeochromocytomas in succinate dehydrogenase B (SDH-B) gene mutation carriers.
|
Clin Endocrinol (Oxf)
|
2008
|
1.32
|
23
|
Rathke's cleft cysts.
|
Clin Endocrinol (Oxf)
|
2012
|
1.32
|
24
|
CT and MR imaging of unusual locations of extra-adrenal paragangliomas (pheochromocytomas).
|
Eur Radiol
|
2004
|
1.29
|
25
|
Expanding role of AMPK in endocrinology.
|
Trends Endocrinol Metab
|
2006
|
1.29
|
26
|
Paraneoplastic syndromes secondary to neuroendocrine tumours.
|
Endocr Relat Cancer
|
2010
|
1.26
|
27
|
Somatostatin analogues in the control of neuroendocrine tumours: efficacy and mechanisms.
|
Endocr Relat Cancer
|
2008
|
1.25
|
28
|
Spectrum and prevalence of FP/TMEM127 gene mutations in pheochromocytomas and paragangliomas.
|
JAMA
|
2010
|
1.22
|
29
|
The optimal imaging of adrenal tumours: a comparison of different methods.
|
Endocr Relat Cancer
|
2007
|
1.19
|
30
|
Macrophage migration inhibitory factor exhibits a pronounced circadian rhythm relevant to its role as a glucocorticoid counter-regulator.
|
Immunol Cell Biol
|
2003
|
1.19
|
31
|
Lymphoma metastasizing to the pituitary: an unusual presentation of a treatable disease.
|
Pituitary
|
2005
|
1.18
|
32
|
The ectopic ACTH syndrome.
|
Rev Endocr Metab Disord
|
2010
|
1.18
|
33
|
Diagnostic accuracy of an "amended" insulin-glucose ratio for the biochemical diagnosis of insulinomas.
|
Ann Intern Med
|
2013
|
1.15
|
34
|
Work-up and management of paediatric Cushing's syndrome.
|
Curr Opin Endocrinol Diabetes Obes
|
2008
|
1.15
|
35
|
Free and total cortisol levels as predictors of severity and outcome in community-acquired pneumonia.
|
Am J Respir Crit Care Med
|
2007
|
1.15
|
36
|
Low O6-methylguanine-DNA methyltransferase (MGMT) expression and response to temozolomide in aggressive pituitary tumours.
|
Clin Endocrinol (Oxf)
|
2008
|
1.15
|
37
|
ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: follow-up and documentation.
|
Neuroendocrinology
|
2009
|
1.15
|
38
|
Genetic analysis of mitochondrial complex II subunits SDHD, SDHB and SDHC in paraganglioma and phaeochromocytoma susceptibility.
|
Clin Endocrinol (Oxf)
|
2003
|
1.14
|
39
|
Fibrosis and carcinoid syndrome: from causation to future therapy.
|
Nat Rev Endocrinol
|
2009
|
1.12
|
40
|
Octreotide and the mTOR inhibitor RAD001 (everolimus) block proliferation and interact with the Akt-mTOR-p70S6K pathway in a neuro-endocrine tumour cell Line.
|
Neuroendocrinology
|
2007
|
1.11
|
41
|
AMP-activated protein kinase mediates glucocorticoid-induced metabolic changes: a novel mechanism in Cushing's syndrome.
|
FASEB J
|
2008
|
1.11
|
42
|
Contrasting clinical manifestations of SDHB and VHL associated chromaffin tumours.
|
Endocr Relat Cancer
|
2009
|
1.09
|
43
|
Clinical and biochemical characteristics of adrenocorticotropin-secreting macroadenomas.
|
J Clin Endocrinol Metab
|
2005
|
1.09
|
44
|
Ghrelin exerts a proliferative effect on a rat pituitary somatotroph cell line via the mitogen-activated protein kinase pathway.
|
Eur J Endocrinol
|
2004
|
1.07
|
45
|
Recent advances in radiological and radionuclide imaging and therapy of neuroendocrine tumours.
|
Eur J Endocrinol
|
2004
|
1.06
|
46
|
Aggressive pituitary tumours: the role of temozolomide and the assessment of MGMT status.
|
Eur J Clin Invest
|
2011
|
1.05
|
47
|
Signaling pathways in pheochromocytomas and paragangliomas: prospects for future therapies.
|
Endocr Pathol
|
2012
|
1.05
|
48
|
Endocrine manifestations in Langerhans cell histiocytosis.
|
Trends Endocrinol Metab
|
2007
|
1.05
|
49
|
Medullary thyroid cancer: molecular biology and novel molecular therapies.
|
Neuroendocrinology
|
2009
|
1.04
|
50
|
Adrenal incidentalomas: 'the rule of four'.
|
Clin Med
|
2008
|
1.04
|
51
|
Paediatric Cushing's syndrome: epidemiology, investigation and therapeutic advances.
|
Trends Endocrinol Metab
|
2007
|
1.02
|
52
|
Fasting and postprandial hyperghrelinemia in Prader-Willi syndrome is partially explained by hypoinsulinemia, and is not due to peptide YY3-36 deficiency or seen in hypothalamic obesity due to craniopharyngioma.
|
J Clin Endocrinol Metab
|
2005
|
1.02
|
53
|
Characterization of aryl hydrocarbon receptor interacting protein (AIP) mutations in familial isolated pituitary adenoma families.
|
Hum Mutat
|
2010
|
1.01
|
54
|
The role of AMP-activated protein kinase in obesity.
|
Front Horm Res
|
2008
|
1.01
|
55
|
Differential gene expression in pituitary adenomas by oligonucleotide array analysis.
|
Eur J Endocrinol
|
2005
|
1.00
|
56
|
Changes in adenosine 5'-monophosphate-activated protein kinase as a mechanism of visceral obesity in Cushing's syndrome.
|
J Clin Endocrinol Metab
|
2008
|
1.00
|
57
|
Are neuroendocrine tumours a feature of tuberous sclerosis? A systematic review.
|
Endocr Relat Cancer
|
2008
|
0.99
|
58
|
Measurement of serum free cortisol shows discordant responsivity to stress and dynamic evaluation.
|
J Clin Endocrinol Metab
|
2007
|
0.99
|
59
|
Insulinomas may present with normoglycemia after prolonged fasting but glucose-stimulated hypoglycemia.
|
J Clin Endocrinol Metab
|
2006
|
0.98
|
60
|
Ipilimumab: a novel immunomodulating therapy causing autoimmune hypophysitis: a case report and review.
|
Eur J Endocrinol
|
2012
|
0.98
|
61
|
Somatostatin analogs modulate AIP in somatotroph adenomas: the role of the ZAC1 pathway.
|
J Clin Endocrinol Metab
|
2012
|
0.98
|
62
|
ARMC5 mutations are common in familial bilateral macronodular adrenal hyperplasia.
|
J Clin Endocrinol Metab
|
2014
|
0.97
|
63
|
Retinoic acid as a novel medical therapy for Cushing's disease in dogs.
|
Endocrinology
|
2006
|
0.97
|
64
|
The pathophysiology of pituitary adenomas.
|
Best Pract Res Clin Endocrinol Metab
|
2009
|
0.97
|
65
|
The prevalence and characteristic features of cyclicity and variability in Cushing's disease.
|
Eur J Endocrinol
|
2009
|
0.95
|
66
|
Association studies on ghrelin and ghrelin receptor gene polymorphisms with obesity.
|
Obesity (Silver Spring)
|
2009
|
0.94
|
67
|
Assessment of p27 (cyclin-dependent kinase inhibitor 1B) and aryl hydrocarbon receptor-interacting protein (AIP) genes in multiple endocrine neoplasia (MEN1) syndrome patients without any detectable MEN1 gene mutations.
|
Clin Endocrinol (Oxf)
|
2008
|
0.94
|
68
|
Adrenocortical carcinoma: the range of appearances on CT and MRI.
|
AJR Am J Roentgenol
|
2011
|
0.94
|
69
|
Clinical, genetic and molecular characterization of patients with familial isolated pituitary adenomas (FIPA).
|
Trends Endocrinol Metab
|
2010
|
0.94
|
70
|
Expression of phosphorylated p27(Kip1) protein and Jun activation domain-binding protein 1 in human pituitary tumors.
|
J Clin Endocrinol Metab
|
2002
|
0.94
|
71
|
A rapid method for analyzing serum pro-insulin-like growth factor-II in patients with non-islet cell tumor hypoglycemia.
|
J Clin Endocrinol Metab
|
2005
|
0.94
|
72
|
Elevated fasting plasma ghrelin in prader-willi syndrome adults is not solely explained by their reduced visceral adiposity and insulin resistance.
|
J Clin Endocrinol Metab
|
2004
|
0.94
|
73
|
Mini-review: pheochromocytomas causing the ectopic ACTH syndrome.
|
Endocrine
|
2012
|
0.93
|
74
|
Combined inhibition of mTORC1 and mTORC2 signaling pathways is a promising therapeutic option in inhibiting pheochromocytoma tumor growth: in vitro and in vivo studies in female athymic nude mice.
|
Endocrinology
|
2013
|
0.92
|
75
|
The clinical presentation (symptoms and signs) of sporadic and familial chromaffin cell tumours (phaeochromocytomas and paragangliomas).
|
Front Horm Res
|
2004
|
0.92
|
76
|
Pheochromocytomas and paragangliomas: assessment of malignant potential.
|
Endocrine
|
2011
|
0.92
|
77
|
Everolimus in the treatment of renal cell carcinoma and neuroendocrine tumors.
|
Adv Ther
|
2010
|
0.92
|
78
|
Diagnosis and localisation of insulinoma: the value of modern magnetic resonance imaging in conjunction with calcium stimulation catheterisation.
|
Eur J Endocrinol
|
2010
|
0.92
|
79
|
Prepubertal Cushing's disease is more common in males, but there is no increase in severity at diagnosis.
|
J Clin Endocrinol Metab
|
2004
|
0.91
|
80
|
The role of ghrelin and ghrelin-receptor gene variants and promoter activity in type 2 diabetes.
|
Eur J Endocrinol
|
2009
|
0.91
|
81
|
CT and MR imaging of the adrenal glands in ACTH-independent cushing syndrome.
|
Radiographics
|
2004
|
0.91
|
82
|
A variation in the ghrelin gene increases weight and decreases insulin secretion in tall, obese children.
|
J Clin Endocrinol Metab
|
2002
|
0.91
|
83
|
Combined blockade of signalling pathways shows marked anti-tumour potential in phaeochromocytoma cell lines.
|
J Mol Endocrinol
|
2012
|
0.90
|
84
|
Heterogeneous genetic background of the association of pheochromocytoma/paraganglioma and pituitary adenoma: results from a large patient cohort.
|
J Clin Endocrinol Metab
|
2014
|
0.90
|
85
|
The rapamycin-derivative RAD001 (everolimus) inhibits cell viability and interacts with the Akt-mTOR-p70S6K pathway in human medullary thyroid carcinoma cells.
|
Mol Cell Endocrinol
|
2009
|
0.89
|
86
|
Advances in the management of paediatric Cushing's disease.
|
Horm Res
|
2008
|
0.89
|
87
|
Preliminary report of the use of everolimus in a patient with progressive medullary thyroid carcinoma.
|
Clin Endocrinol (Oxf)
|
2012
|
0.89
|
88
|
Whole-exome sequencing studies of nonfunctioning pituitary adenomas.
|
J Clin Endocrinol Metab
|
2013
|
0.89
|
89
|
The diagnosis and management of parasellar tumours of the pituitary.
|
Endocr Relat Cancer
|
2008
|
0.88
|
90
|
Sequence analysis of the PRKAR1A gene in sporadic somatotroph and other pituitary tumours.
|
Clin Endocrinol (Oxf)
|
2002
|
0.88
|
91
|
Factors influencing cure by transsphenoidal selective adenomectomy in paediatric Cushing's disease.
|
Eur J Endocrinol
|
2005
|
0.87
|
92
|
A prospective evaluation of postural stimulation testing, computed tomography and adrenal vein sampling in the differential diagnosis of primary aldosteronism.
|
Clin Endocrinol (Oxf)
|
2012
|
0.87
|
93
|
Long-term remission and recurrence rates in Cushing's disease: predictive factors in a single-centre study.
|
Eur J Endocrinol
|
2013
|
0.87
|
94
|
Diagnosing unilateral primary aldosteronism - comparison of a clinical prediction score, computed tomography and adrenal venous sampling.
|
Clin Endocrinol (Oxf)
|
2013
|
0.87
|
95
|
Landscape of Familial Isolated and Young-Onset Pituitary Adenomas: Prospective Diagnosis in AIP Mutation Carriers.
|
J Clin Endocrinol Metab
|
2015
|
0.86
|
96
|
Cushing's disease in children and adolescents: 20 years of experience in a single neurosurgical center.
|
Neurosurgery
|
2005
|
0.86
|
97
|
The role of somatostatin analogues in the treatment of neuroendocrine tumours.
|
Mol Cell Endocrinol
|
2007
|
0.86
|
98
|
Cyclins and their related proteins in pituitary tumourigenesis.
|
Mol Cell Endocrinol
|
2010
|
0.86
|
99
|
Cell cycle dysregulation in pituitary oncogenesis.
|
Front Horm Res
|
2004
|
0.86
|
100
|
Is urinary free cortisol of value in the diagnosis of Cushing's syndrome?
|
Curr Opin Endocrinol Diabetes Obes
|
2011
|
0.86
|
101
|
MicroRNA miR-107 is overexpressed in pituitary adenomas and inhibits the expression of aryl hydrocarbon receptor-interacting protein in vitro.
|
Am J Physiol Endocrinol Metab
|
2012
|
0.86
|
102
|
Single photon emission computed tomography (SPECT)/computed tomography using Iodine-123 in patients with differentiated thyroid cancer: additional value over whole body planar imaging and SPECT.
|
Eur J Endocrinol
|
2010
|
0.85
|
103
|
Ghrelin's role as a major regulator of appetite and its other functions in neuroendocrinology.
|
Prog Brain Res
|
2010
|
0.85
|
104
|
Targeting MAPK (Ras/ERK) and PI3K/Akt pathways in pituitary tumorigenesis.
|
Expert Opin Ther Targets
|
2009
|
0.85
|
105
|
Somatostatin analogues stimulate p27 expression and inhibit the MAP kinase pathway in pituitary tumours.
|
Eur J Endocrinol
|
2006
|
0.85
|
106
|
Cushing syndrome secondary to a thymic carcinoid tumor due to multiple endocrine neoplasia type 1.
|
Endocr Pract
|
2011
|
0.84
|
107
|
Specific electrocardiographic features associated with Cushing's disease.
|
Clin Endocrinol (Oxf)
|
2011
|
0.84
|
108
|
Differential diagnosis of Cushing's syndrome.
|
Arq Bras Endocrinol Metabol
|
2007
|
0.84
|
109
|
The 2004 World Health Organization classification of pituitary tumors: is it clinically helpful?
|
Acta Neuropathol
|
2005
|
0.84
|
110
|
The clinical significance of adrenal incidentalomas.
|
Eur J Clin Invest
|
2011
|
0.83
|
111
|
PPAR-gamma expression in pituitary tumours and the functional activity of the glitazones: evidence that any anti-proliferative effect of the glitazones is independent of the PPAR-gamma receptor.
|
Clin Endocrinol (Oxf)
|
2006
|
0.83
|
112
|
ACTH and alpha-MSH inhibit leptin expression and secretion in 3T3-L1 adipocytes: model for a central-peripheral melanocortin-leptin pathway.
|
Mol Cell Endocrinol
|
2003
|
0.83
|
113
|
Phaeochromocytoma crisis presenting with profound hypoglycaemia and subsequent hypertension.
|
Hormones (Athens)
|
2009
|
0.83
|
114
|
Reduced expression of the growth hormone and type 1 insulin-like growth factor receptors in human somatotroph tumours and an analysis of possible mutations of the growth hormone receptor.
|
Clin Endocrinol (Oxf)
|
2003
|
0.83
|
115
|
Differential diagnosis of adrenocorticotropic hormone-independent Cushing syndrome: role of adrenal venous sampling.
|
Endocr Pract
|
2012
|
0.83
|
116
|
Endonasal endoscopic transsphenoidal pituitary surgery: early experience and outcome in paediatric Cushing's disease.
|
Clin Endocrinol (Oxf)
|
2013
|
0.83
|
117
|
A mutation and expression analysis of the oncogene BRAF in pituitary adenomas.
|
Clin Endocrinol (Oxf)
|
2007
|
0.82
|
118
|
Diagnosis of insulinoma in a patient with hypoglycemia without obvious hyperinsulinemia.
|
Nat Rev Endocrinol
|
2009
|
0.82
|
119
|
Role of regulatory factors in pituitary tumour formation.
|
Front Horm Res
|
2004
|
0.82
|
120
|
Oncogene-induced senescence in pituitary adenomas and carcinomas.
|
Hormones (Athens)
|
2012
|
0.82
|
121
|
Vasopressin receptor antagonist in the treatment of the syndrome of inappropriate antidiuretic hormone in general hospital practice.
|
Endocr J
|
2012
|
0.82
|
122
|
Multimodality palliative treatment of (111)In-pentetreotide negative/(123)I-MIBG positive metastatic carcinoid - a case report.
|
Endokrynol Pol
|
2008
|
0.82
|
123
|
The management of head-and-neck paragangliomas.
|
Endocr Relat Cancer
|
2013
|
0.82
|
124
|
Mutational analysis of the adaptor protein 2 sigma subunit (AP2S1) gene: search for autosomal dominant hypocalcemia type 3 (ADH3).
|
J Clin Endocrinol Metab
|
2014
|
0.81
|
125
|
Modifications in basal and stress-induced hypothalamic AMP-activated protein kinase (AMPK) activity in rats chronically treated with an angiotensin II receptor blocker.
|
Stress
|
2012
|
0.81
|
126
|
Pituitary gland and beta-catenin signaling: from ontogeny to oncogenesis.
|
Pituitary
|
2009
|
0.81
|
127
|
The Wnt signalling cascade and the adherens junction complex in craniopharyngioma tumorigenesis.
|
Endocr Pathol
|
2015
|
0.81
|
128
|
Novel insights in the diagnosis of Cushing's syndrome.
|
Neuroendocrinology
|
2010
|
0.80
|
129
|
CB1 receptor mediates the effects of glucocorticoids on AMPK activity in the hypothalamus.
|
J Endocrinol
|
2013
|
0.80
|
130
|
Does hypopituitarism recover when macroprolactinomas are treated with cabergoline?
|
Clin Endocrinol (Oxf)
|
2013
|
0.80
|
131
|
Ghrelin and cannabinoids require the ghrelin receptor to affect cellular energy metabolism.
|
Mol Cell Endocrinol
|
2012
|
0.80
|
132
|
Carcinoid Heart Disease: From Pathophysiology to Treatment--'Something in the Way It Moves'.
|
Neuroendocrinology
|
2015
|
0.80
|
133
|
Evaluation of an enzyme immunoassay for plasma-free metanephrines in the diagnosis of catecholamine-secreting tumors.
|
Eur J Endocrinol
|
2009
|
0.80
|
134
|
Confusing genes: a patient with MEN2A and Cushing's disease.
|
Clin Endocrinol (Oxf)
|
2013
|
0.80
|
135
|
Cushing's syndrome with low levels of serum cortisol: the role of inhaled steroids.
|
Clin Med
|
2011
|
0.79
|
136
|
Assessment of serum-free cortisol levels in patients with adrenocortical carcinoma treated with mitotane: a pilot study.
|
Clin Endocrinol (Oxf)
|
2009
|
0.79
|
137
|
Diagnosis and treatment of pediatric Cushing's disease.
|
Pituitary
|
2007
|
0.79
|
138
|
Targeted radionuclide therapy for neuroendocrine tumours: principles and application.
|
Neuroendocrinology
|
2009
|
0.79
|
139
|
Pediatric Cushing's syndrome: clinical features, diagnosis, and treatment.
|
Arq Bras Endocrinol Metabol
|
2007
|
0.79
|
140
|
Osteoporosis in Cushing's syndrome.
|
Front Horm Res
|
2002
|
0.78
|
141
|
Secondary forms of polycystic ovary syndrome.
|
Trends Endocrinol Metab
|
2004
|
0.78
|
142
|
The expression of the F-box protein Skp2 is negatively associated with p27 expression in human pituitary tumors.
|
Pituitary
|
2002
|
0.78
|
143
|
Protein western array analysis in human pituitary tumours: insights and limitations.
|
Endocr Relat Cancer
|
2008
|
0.78
|
144
|
Imaging in Cushing's syndrome.
|
Arq Bras Endocrinol Metabol
|
2007
|
0.78
|
145
|
A comparison of a novel testosterone bioadhesive buccal system, striant, with a testosterone adhesive patch in hypogonadal males.
|
J Clin Endocrinol Metab
|
2004
|
0.78
|
146
|
The management of differentiated thyroid cancer using 123I for imaging to assess the need for 131I therapy.
|
Nucl Med Commun
|
2006
|
0.78
|
147
|
Imaging in covert ectopic ACTH secretion: a CT pictorial review.
|
Eur Radiol
|
2009
|
0.78
|
148
|
Growth and growth hormone secretion in paediatric Cushing's disease.
|
Hormones (Athens)
|
2006
|
0.77
|
149
|
Acromegaly: Beyond surgery.
|
Indian J Endocrinol Metab
|
2013
|
0.77
|
150
|
Where metabolism meets oncogenesis: another false lead?
|
Lancet Oncol
|
2010
|
0.77
|
151
|
Ectopic ACTH syndrome.
|
Front Horm Res
|
2006
|
0.77
|
152
|
The pathology of pituitary adenomas from a clinical perspective.
|
Front Biosci (Schol Ed)
|
2011
|
0.77
|
153
|
Pituitary tumors in 2010: a new therapeutic era for pituitary tumors.
|
Nat Rev Endocrinol
|
2011
|
0.77
|
154
|
Treatment of advanced neuroendocrine tumours with the radiolabelled somatostatin analogue octreotide.
|
Hormones (Athens)
|
2006
|
0.77
|
155
|
The molecular pathogenesis of corticotroph tumours.
|
Eur J Clin Invest
|
2011
|
0.76
|
156
|
Familial paraganglioma: a novel presentation of a case and response to therapy with radiolabelled MIBG.
|
Hormones (Athens)
|
2006
|
0.76
|
157
|
Pituitary-targeted medical therapy of Cushing's disease.
|
Expert Opin Investig Drugs
|
2008
|
0.76
|
158
|
Medical therapy of Cushing's disease: where are we now?
|
Front Horm Res
|
2010
|
0.76
|
159
|
Current concepts in the diagnosis and management of type 1 gastric neuroendocrine neoplasms.
|
Clin Endocrinol (Oxf)
|
2014
|
0.76
|
160
|
Dynamic testing in Cushing's syndrome.
|
Pituitary
|
2008
|
0.76
|
161
|
A single-center open-label study to investigate the efficacy and safety of repeated subcutaneous injections of lanreotide Autogel in patients with acromegaly previously treated with octreotide.
|
Endocr Pract
|
2010
|
0.76
|
162
|
The CB1 receptor mediates the peripheral effects of ghrelin on AMPK activity but not on growth hormone release.
|
FASEB J
|
2013
|
0.76
|
163
|
Are serotonin metabolite levels related to bone mineral density in patients with neuroendocrine tumours?
|
Clin Endocrinol (Oxf)
|
2013
|
0.76
|
164
|
Characterization of SNARE proteins in human pituitary adenomas: targeted secretion inhibitors as a new strategy for the treatment of acromegaly?
|
J Clin Endocrinol Metab
|
2013
|
0.76
|
165
|
Identification of adrenocorticotropin receptor messenger ribonucleic acid in the human pituitary and its loss of expression in pituitary adenomas.
|
J Clin Endocrinol Metab
|
2003
|
0.76
|
166
|
Emerging drugs for Cushing's disease.
|
Expert Opin Emerg Drugs
|
2015
|
0.76
|
167
|
Diagnosing diabetes on admission hyperglycaemia.
|
Heart
|
2011
|
0.75
|
168
|
The potential role of D(2) dopamine receptors as a target in the management of neuroendocrine tumors.
|
Cancer Biol Ther
|
2008
|
0.75
|
169
|
The heme oxygenase-carbon monoxide pathway in the control of neuroendocrine function.
|
Front Horm Res
|
2002
|
0.75
|
170
|
Prognostic value of the apoptotic index analysed jointly with selected cell cycle regulators and proliferation markers in non-small cell lung cancer.
|
Lung Cancer
|
2009
|
0.75
|
171
|
Changes in the Epidemiology of Neuroendocrine Tumours.
|
Neuroendocrinology
|
2015
|
0.75
|
172
|
Dandy-Walker malformation, papillary thyroid carcinoma, and SDHD-associated paraganglioma syndrome.
|
J Clin Endocrinol Metab
|
2013
|
0.75
|
173
|
A thymic carcinoid tumour causing Zollinger-Ellison and Cushing's syndromes due to ectopic ACTH and gastrin secretion.
|
Hormones (Athens)
|
2013
|
0.75
|
174
|
A case of hiccoughs.
|
Clin Med
|
2011
|
0.75
|
175
|
Molecular pathways of human adrenocortical carcinoma - translating cell signalling knowledge into diagnostic and treatment options.
|
Endokrynol Pol
|
2016
|
0.75
|
176
|
GnRH analogue use in postmenopausal hyperandrogenism: long-term remission.
|
Endocrine
|
2012
|
0.75
|
177
|
Recurrent pituitary ependymoma: a complex clinical problem.
|
Pituitary
|
2010
|
0.75
|
178
|
Diagnosis and treatment of Cushing's disease in children.
|
Endocr Dev
|
2009
|
0.75
|
179
|
Thymic Neuroendocrine Neoplasms: Biological Behaviour and Therapy.
|
Neuroendocrinology
|
2017
|
0.75
|
180
|
Transsphenoidal pituitary surgery in the elderly is safe and effective.
|
Br J Neurosurg
|
2013
|
0.75
|
181
|
Investigation for Paediatric Cushing's Syndrome Using Twenty-Four-Hour Urinary Free Cortisol Determination.
|
Horm Res Paediatr
|
2016
|
0.75
|
182
|
Cancer in the thyroid is not always thyroid cancer.
|
Hormones (Athens)
|
2006
|
0.75
|
183
|
Pituitary radiotherapy.
|
Pituitary
|
2009
|
0.75
|
184
|
Examining the candidacy of ghrelin as a gene responsible for variation in adult stature in a United Kingdom population with type 2 diabetes.
|
J Clin Endocrinol Metab
|
2007
|
0.75
|